| Title： | Expert Consensus on diagnosis and treatment of dilated cardiomyopathy in children |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Use of this consensus includes pediatric cardiovascular physicians, pediatric physician, and general practitioners. |
| Evidence classification method： | The evidence recommendation grading evaluation, formulation and evaluation method (GRADE) was used to determine the recommendation level of a clinical issue in this consensus according to the credibility level of literature or data under the guidance of the GRADE manual. |
| Development unit： | Collaborating Group of Precise Diagnosis and Treatment of Cardiomyopathy，Chinese Pediatric Cardiology Society, Chinese Pediatric Society, Chinese Medical Association; Collaborating Group of Heart Failure, Chinese Pediatric Cardiology Society, Chinese Pediatric Society, Chinese Medical Association |
| Registration time: | 2023-03-16 |
| Registration number： | PREPARE-2023CN165 |
| Purpose of the guideline: | Dilated cardiomyopathy (DCM) is the most common type of childhood cardiomyopathy, mainly manifested by cardiac enlargement, systolic insufficiency and heart failure. The prognosis of dilated cardiomyopathy is poor and the mortality is high. Therefore, to improve the understanding of this disease, early diagnosis and treatment are crucial to improve the prognosis. At present, there is no consensus on diagnosis and treatment of dilated cardiomyopathy in children. Therefore, we gathered domestic experts in related fields to write this consensus, in order to provide guidance and suggestions for the management of pediatric dilated cardiomyopathy. |
